why choose us

Clinical Trials Search

Showing 16,380 of 132,963 result(s)
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+;HER2- Breast Cancer With an ESR1 Mutation

Status: Completed

Condition: Metastatic Breast Cancer

Interventions: 5 mg;d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day

Date: 2023-01-13

Identifying Markers of Exercise Training in Heart Failure

Status: NOT_YET_RECRUITING

Condition: Heart Failure

Interventions: 12 week program of standard clinical cardiac rehabilitation for patients with symptomatic heart failure.
Patients undergo 3-times weekly sessions

Date: 2023-01-13

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Status: Completed

Condition: Symptomatic Neurogenic Orthostatic Hypotension

Interventions: Oral tablet, QD

Date: 2023-01-13

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Status: Completed

Condition: Dermatomyositis

Interventions: GLPG3667 capsules will be administered per dose and schedule specified in the arm description.

Date: 2023-01-13

STEPS Implementation Trial

Status: Completed

Condition: Autism Spectrum Disorder

Interventions: behavioral counseling

Date: 2023-01-13

Selective Lipopolysaccharide Hemosorption in Maternal Sepsis

Status: COMPLETED

Condition: Maternal sepsIs

Interventions: Hemoperfusion using continuous extracorporeal LPS adsorption with Efferon LPS therapeutic device during a period of 12h immediately following admissio

Date: 2023-01-13

Predicting Peanut Anaphylaxis and Reducing Epinephrine

Status: COMPLETED

Condition: Anaphylaxis Food

Interventions: The oral food challenge will be done as usual, and participants will wear the TEWL monitor.
The research food allergy nurse and doctor will also

Date: 2023-01-13

Non-pharmacological Methods for the Control of Anxiety and Pain During Outpatient Hysteroscopy

Status: COMPLETED

Condition: Pain, Postoperative

Interventions: In-office hysteroscopic procedures were conducted using a 5mm continuous flow Office Hysteroscope using a vaginoscopic, no-touch, approach

Date: 2023-01-13

Janus Kinase Inhibition in Sarcoidosis

Status: COMPLETED

Condition: Sarcoidosis

Interventions: Abrocitinib (Cibinqo) is FDA approved at 200 mg dose once daily for the treatment of atopic dermatitis.
It is not currently FDA approved for the

Date: 2023-01-13

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

Status: COMPLETED

Condition: Epstein-Barr Virus Infection

Interventions: Matrix-M1 is composed of 2 types of 40 nm-sized particles each with a different saponin fraction (fraction A and fraction B) combined with cholesterol

Date: 2023-01-12